JRS PHARMA has announced the upcoming grand opening of a new laboratory located at their Diadema, Brazil location. The lab is scheduled to be opened during JRS PHARMA’s Latin America Technical Seminar on June 26-27, 2017.

JRS PHARMA has announced the worldwide release of the Povidone Family product line, the latest addition to their excipients portfolio. This product line consists of three products: VIVAPHARM® PVP (Povidone), VIVAPHARM® PVP/VA 64 (Copovidone), and VIVAPHARM® PVPP (Crospovidone).

JRS PHARMA products can now be purchased direct in India. All business has been transferred from S. Zhaveri Pharmakem Pvt. Ltd. to Rettenmaier India Pvt. Ltd., a wholly owned subsidiary of the JRS Group ( J. RETTENMAIER & Söhne)

JRS PHARMA, headquartered in Germany, has entered into a joint venture agreement with SSP, headquartered in Chongqing, China, for the commercialization of povidone products. The new JV company is Star-Tech & JRS Specialty Products.